Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
DARE — Dare Bioscience, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 26, 2026
REVENUE
$1.0M +45155.3%
NET MARGIN
-140.8% +157364.3 PTS
EPS
-$0.10 +64.5%
FREE CASH FLOW
$1.2M +300.6%

No summary has been written for this call yet.